1-47994174-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001194986.2(TRABD2B):āc.526A>Gā(p.Arg176Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000163 in 1,538,346 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001194986.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRABD2B | NM_001194986.2 | c.526A>G | p.Arg176Gly | missense_variant | 2/7 | ENST00000606738.3 | NP_001181915.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRABD2B | ENST00000606738.3 | c.526A>G | p.Arg176Gly | missense_variant | 2/7 | 1 | NM_001194986.2 | ENSP00000476820.1 | ||
TRABD2B | ENST00000435576.2 | n.39A>G | non_coding_transcript_exon_variant | 1/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000574 AC: 8AN: 139294Hom.: 0 AF XY: 0.0000662 AC XY: 5AN XY: 75510
GnomAD4 exome AF: 0.000175 AC: 243AN: 1386120Hom.: 0 Cov.: 31 AF XY: 0.000159 AC XY: 109AN XY: 684106
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 10, 2024 | The c.526A>G (p.R176G) alteration is located in exon 2 (coding exon 2) of the TRABD2B gene. This alteration results from a A to G substitution at nucleotide position 526, causing the arginine (R) at amino acid position 176 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at